Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
The report details the trend, potential and market size of Anti Asthma Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti Asthma Drugsmarket, defines the market attractiveness level of Anti Asthma Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti Asthma Drugs industry, describes the types of Anti Asthma Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti Asthma Drugs market and the development prospects and opportunities of Anti Asthma Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti Asthma Drugs market in Chapter 13.
By Player:
Teva Pharmaceutical
GlaxoSmithKline
Boehringer Ingelheim
Novartis International
F Hoffmann-La Roche
AstraZeneca
Merck & Co
Sunovion Pharmaceuticals
By Type:
Bronchodilators
Leukotriene antagonists
Mast cell stabilizers
Corticosteroids
Monoclonal antibody
By End-User:
Clinics
Hospitals
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti Asthma Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti Asthma Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti Asthma Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti Asthma Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti Asthma Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti Asthma Drugs Consumption (2017-2022)
-
7.2 United States Anti Asthma Drugs Consumption (2017-2022)
-
7.3 Europe Anti Asthma Drugs Consumption (2017-2022)
-
7.4 China Anti Asthma Drugs Consumption (2017-2022)
-
7.5 Japan Anti Asthma Drugs Consumption (2017-2022)
-
7.6 India Anti Asthma Drugs Consumption (2017-2022)
-
7.7 South Korea Anti Asthma Drugs Consumption (2017-2022)
8 Region and Country-wise Anti Asthma Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti Asthma Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti Asthma Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti Asthma Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti Asthma Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti Asthma Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti Asthma Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti Asthma Drugs Consumption Forecast (2022-2028)
9 Global Anti Asthma Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti Asthma Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Leukotriene antagonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Mast cell stabilizers Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Monoclonal antibody Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti Asthma Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti Asthma Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti Asthma Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Leukotriene antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Mast cell stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Monoclonal antibody Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti Asthma Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti Asthma Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti Asthma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti Asthma Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti Asthma Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti Asthma Drugs Market Competitive Analysis
-
14.1 Teva Pharmaceutical
-
14.1.1 Teva Pharmaceutical Company Details
-
14.1.2 Teva Pharmaceutical Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva Pharmaceutical Anti Asthma Drugs Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Anti Asthma Drugs Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim Anti Asthma Drugs Product and Service
-
14.4 Novartis International
-
14.4.1 Novartis International Company Details
-
14.4.2 Novartis International Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis International Anti Asthma Drugs Product and Service
-
14.5 F Hoffmann-La Roche
-
14.5.1 F Hoffmann-La Roche Company Details
-
14.5.2 F Hoffmann-La Roche Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Anti Asthma Drugs Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Anti Asthma Drugs Product and Service
-
14.7 Merck & Co
-
14.7.1 Merck & Co Company Details
-
14.7.2 Merck & Co Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck & Co Anti Asthma Drugs Product and Service
-
14.8 Sunovion Pharmaceuticals
-
14.8.1 Sunovion Pharmaceuticals Company Details
-
14.8.2 Sunovion Pharmaceuticals Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sunovion Pharmaceuticals Anti Asthma Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti Asthma Drugs
-
Figure Anti Asthma Drugs Picture
-
Table Global Anti Asthma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti Asthma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti Asthma Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti Asthma Drugs Consumption by Country (2017-2022)
-
Figure United States Anti Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti Asthma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti Asthma Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti Asthma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Leukotriene antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Mast cell stabilizers Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukotriene antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mast cell stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti Asthma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti Asthma Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Anti Asthma Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti Asthma Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Anti Asthma Drugs Product and Service
-
Table Novartis International (Foundation Year, Company Profile and etc.)
-
Table Novartis International Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International Anti Asthma Drugs Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Anti Asthma Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anti Asthma Drugs Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Anti Asthma Drugs Product and Service
-
Table Sunovion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunovion Pharmaceuticals Anti Asthma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Pharmaceuticals Anti Asthma Drugs Product and Service
-
